57f33dc4_id_reviews__first_test_results__Cochrane_conclusion
[Our score] 0.39 [Our narrative conclusion] likely to be effective [Agree?] Y [Cochrane conclusion] 
Limited data were available when considering the impact of galantamine on vascular dementia or vascular cognitive impairment. The data available suggest some advantage over placebo in the areas of cognition and global clinical state. In both included trials galantamine produced higher rates of gastrointestinal side-effects. More studies are needed before firm conclusions can be drawn.
Liberating the literature: Ultra-rapid reviews, first test results
Cochrane conclusion